Zions Bancorporation, National Association’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$8.37M Sell
297,962
-41,219
-12% -$1.1M 0.54% 25
2025
Q4
$8.45M Buy
339,181
+1,084
+0.3% +$27.3K 0.39% 37
2025
Q3
$8.61M Sell
338,097
-6,528
-2% -$161K 0.43% 38
2025
Q2
$8.35M Buy
344,625
+69,497
+25% +$1.62M 0.45% 37
2025
Q1
$6.97M Buy
+275,128
New +$7.2M 0.44% 42

Other funds holding PFE

Zions Bancorporation, National Association's PFE Position: Q1 2026 in Review

Zions Bancorporation, National Association reduced its Pfizer (PFE) stake by 12% in Q1 2026, selling an estimated $1.1M and leaving 297,962 shares worth $8.37M. The position accounts for 0.54% of the portfolio, ranked #25.

Zions Bancorporation, National Association first reported a position in PFE in Q1 2025 and has held it in 5 quarters since. The position peaked at $8.61M in Q3 2025. 2,939 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Zions Bancorporation, National Association held 297,962 shares of Pfizer worth $8.37M as of Q1 2026.
  • Zions Bancorporation, National Association sold 41,219 Pfizer shares in Q1 2026, an estimated $1.1M.
  • Pfizer made up 0.54% of Zions Bancorporation, National Association's portfolio in Q1 2026, its #25 holding.
  • Zions Bancorporation, National Association first reported a position in Pfizer in Q1 2025 and has held it in 5 quarters since.
  • Zions Bancorporation, National Association's Pfizer position peaked at $8.61M in Q3 2025.
  • 2,939 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Zions Bancorporation, National Association's 13F filing for Q1 2026, filed 8 May 2026.